Second-trimester maternal serum ca-125 versus estriol in the multiple-marker screening test for down syndrome

Obstetrical and Gynecological Survey

Volumn 89, Issue 3, 1997, Pages 359-363

  Wenstrom, Katharine D ^a   Owen, John ^a   Boots, Larry ^a  

^a Division of Maternal Fetal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CA 125 ANTIGEN;

ARTICLE; CHROMOSOME ABERRATION; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ADULT; CA-125 ANTIGEN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 0031106508     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1080/00006250-199703000-00008     Document Type: Article

References (23)

1. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
2. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 1993; 81:72-7.
3. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-7.
4. Kabawat SE, Bast RC Jr, Bhan A, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 1983;2:275-85.
5. Quirk JG, Brunson GL, Long CA, Bannon GA, Sanders M, O'Brien TJ. CA-125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol 1988;159:644-9.
6. Itahashi K, Inaba N, Fukazawa I, Takamizawa H. Immunoradio-metrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA-125) in pregnancy and at delivery. Arch Gynecol Obstet 1988;243:191-7.
7. van Lith JMM, Mantingh A, Beekhuis JR, de Bruijn WA. First trimester CA-125 and Down's syndrome. Br J Obstet Gynaecol 1991;98:493-4.
8. Hogdall CK, Hagdall EV, Arends J, Nergaard-Pedersen B, Smidt-Jensen S, Larsen SO. CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters. Prenat Diag 1992;12:223-7.
9. van Blerk M, Smitz J, De Catte L, Kumps C, van der Elst J, van Steirteghem AC. Second-trimester cancer antigen 125 and Down's syndrome. Prenat Diag 1992;12:1062-6.
10. Norton ME, Golbus MS. Maternal serum CA-125 for aneuploidy detection in early pregnancy. Prenat Diag 1992;12:779-81.
11. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Roystom P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988;297:883-7.
12. Canick JA, Knight GJ. Multiple-marker screening for fetal Down syndrome. Contemp Obstet Gynecol 1992;(Technology Edition): 25-42.
13. Koboyashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, et al. Mechanism and clinical significance of elevated CA-125 levels in the sera of pregnant women. Am J Obstet Gynecol 1989;160: 153-6.
14. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between lowr maternal serum a-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
15. Kratzer PG, Golbus MS, Monroe SE, Finkelstein DE, Taylor RN. First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone. Prenat Diagn 1991;11:751-65.
16. Brambati B, Macintosh MCM, Teisner B, Maguiness S, Shrimauker K, Lanzani A, et al. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol 1993;100:324-6.
17. Brock DJH, Barron L, Holloway S, Liston WA, Hillier SG, Seppala M. First trimester maternal serum biochemical indicators in Down syndrome. Prenat Diagn 1990;10:245-51.
18. Ind TE, lies RK, Wathen NC, Murugan P, Campbell J, Macintosh M, et al. Low levels of amniotic fluid placental alkaline phosphatase in Down's syndrome. Br J Obstet Gynaecol 1993;100:847-9.
19. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309: 883-7.
20. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC Jr. CA-125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol 1984;64:703-7.
21. Takahashi K, Yamane Y, Yoshino K, Shibukawa T, Matsunaga I, Kitao M. Studies on serum CA-125 levels in pregnant women. Acta Obstet Gynaecol 1985;37:1931-4.
22. Seki K, Kikuchi Y, Uesato T, Kato K. Increased serum CA-125 levels during the first trimester of pregnancy. Acta Obstet Gynaecol Scand 1986;65:583-5.
23. Check JH, Nowroozi K, Vaze M, Wapner R, Seefried L. Very high CA-125 levels during early first trimester in three cases of spontaneous abortion with chromosomal abnormalities. Am J Obstet Gynecol 1990;162:674-5.